KPMG Acceleris

Power Roll Limited is a UK-based company that develops and commercializes innovative energy storage and generation technologies. Established in 2012, the company produces advanced products including supercapacitors, batteries, and ultra-thin flexible solar photovoltaic (PV) films. Power Roll’s proprietary technology allows for the manufacturing of solar films in continuous rolls using a rapid, low-cost process, making it suitable for various applications, including automotive and smart grid systems. With a robust portfolio of 15 patent families, the company focuses on energy storage, solar PV, and nano-barrier technologies, positioning itself as a disruptive force in the renewable energy sector.

Reacta Biotech has been established to develop, manufacture and commercialise oral food challenge materials to pharmaceutical standards of Good Manufacturing Practice (GMP).

Vertical Future Limited produces fruits and vegetables in vertical gardens in controlled environments. The company was founded in 2016 and is headquartered in London, United Kingdom.

ADC Biotechnology Ltd produces new antibody drug conjugate based anti-cancer drugs in the oncology field. The company offers Lock-Release, a drug purification process that eliminates several steps, purification equipment, and reduces process risks. It also offers a range of consultancy and R&D services for drug developers and manufacturers. ADC Biotechnology Ltd was formerly known as Reaxa Biotech Ltd and changed its name to ADC Biotechnology Ltd in May 2010. The company was founded in 2010 and is based in St Asaph, United Kingdom.

The novel and broadly validated Redox Switch™ approach allows Redag Crop Protection to begin with best in class crop protection products and find new intellectual property that supports development of novel agrochemicals. These properties have shorter less costly development cycles bringing rapid innovation to the industry. There is a growing need for new products as older ones are withdrawn either for safety reasons or because resistance has developed that reduces performance.

Apex Molecular Ltd provides specialist chemistry services to pharmaceutical, biotechnology (life sciences), and applied chemistry sectors. The company offers laboratory-scale chemistry development services, including high potency synthesis, custom/contract synthesis, and development and scale-up. Its customers include drug discovery, biotechnology, and agritech companies. The company was formerly known as YProTech Ltd. and changed its name to Apex Molecular Ltd in 2019. Apex Molecular Ltd was incorporated in 2008 and is based in Alderley Edge, United Kingdom.

The novel and broadly validated Redox Switch™ approach allows Redag Crop Protection to begin with best in class crop protection products and find new intellectual property that supports development of novel agrochemicals. These properties have shorter less costly development cycles bringing rapid innovation to the industry. There is a growing need for new products as older ones are withdrawn either for safety reasons or because resistance has developed that reduces performance.

InvestingZone Limited develops online equity crowdfunding platform to facilitate the investment market. Its platform enables early-stage and growth companies to raise money from a large pool of experienced investors; and provides those investors with the same vital rights and protections demanded by venture capitalists. The company also allows investors to build and manage portfolios, vote online, track investment performance, make follow on investments, and network using the platform messaging service directly with companies and shareholders. It serves unlisted companies and professional investors. The company was incorporated in 2012 and is based in London, United Kingdom.

TheraCryf PLC is a clinical-stage biotechnology company specializing in the development of treatments for oncology and neuropsychiatry. The company is centered on its proprietary Sulforadex technology, which involves synthetic and stabilized analogues of the compound sulforaphane, known for its potential therapeutic effects. TheraCryf's lead product, SFX-01, is a patented formulation of sulforaphane currently undergoing Phase II clinical trials for metastatic breast cancer and subarachnoid hemorrhage. Additionally, SFX-01 is in preclinical development for multiple sclerosis and is being evaluated clinically for various conditions, including prostate cancer, autism, non-alcoholic steatohepatitis, and chronic kidney diseases. Founded in 2007 and headquartered in Wilmslow, United Kingdom, TheraCryf aims to leverage its innovative technology to advance scientific discoveries into viable commercial therapies.

EveryCloud Computing is a cloud security company that specializes in email security and data protection services. Founded in 2009 by Graham O'Reilly and his partner, the firm has focused on delivering responsive and versatile support alongside secure technology, establishing itself as a leader in the market. EveryCloud filters over 300 million emails monthly for more than 2,000 organizations across 13 countries, with a strong presence in the United Kingdom and the United States. The company offers a range of services, including cloud desktop solutions for various devices, enabling users to store and exchange files securely. Additionally, EveryCloud provides comprehensive data protection, including cloud-based backup and disaster recovery services. With dedicated account managers and support representatives, customers receive expert guidance throughout their journey, from setup to renewal, ensuring a seamless experience.

The novel and broadly validated Redox Switch™ approach allows Redag Crop Protection to begin with best in class crop protection products and find new intellectual property that supports development of novel agrochemicals. These properties have shorter less costly development cycles bringing rapid innovation to the industry. There is a growing need for new products as older ones are withdrawn either for safety reasons or because resistance has developed that reduces performance.

Reacta Biotech has been established to develop, manufacture and commercialise oral food challenge materials to pharmaceutical standards of Good Manufacturing Practice (GMP).

ADC Biotechnology Ltd produces new antibody drug conjugate based anti-cancer drugs in the oncology field. The company offers Lock-Release, a drug purification process that eliminates several steps, purification equipment, and reduces process risks. It also offers a range of consultancy and R&D services for drug developers and manufacturers. ADC Biotechnology Ltd was formerly known as Reaxa Biotech Ltd and changed its name to ADC Biotechnology Ltd in May 2010. The company was founded in 2010 and is based in St Asaph, United Kingdom.

Femeda Ltd. is a UK-based company specializing in the development and manufacturing of medical devices aimed at treating female urinary incontinence. Established in 2002 and located in Cramlington, Femeda focuses on creating innovative solutions to address bladder leakage issues caused by weak pelvic floor muscles. Its flagship product, Pelviva, employs electro stimulation technology to proactively treat incontinence, enhancing the quality of life for women affected by this condition. The company's research and development efforts are driven by consumer needs, ensuring that Pelviva is designed to provide effective support. With backing from a dedicated group of investors, Femeda has successfully advanced its R&D program, leading to the product's anticipated launch.

MicroVisk Limited, founded in 2004 and based in Oxford, United Kingdom, specializes in medical technology. The company has developed CoagMax, a point-of-care monitor that enables home testing for prothrombin time (PT) and international normalized ratio (INR) blood tests. In addition, MicroVisk is engaged in the creation of Micro Electro Mechanical Sensors, targeting the international medical market. By focusing on innovative solutions for blood testing and medical device technologies, MicroVisk aims to enhance patient care and facilitate easier access to vital health information.